Novavax has delayed first-quarter shipments in Europe and lower income countries such as the Philippines.NEW YORK - Novavax Inc has delivered just a small fraction of the two billion Covid-19 shots it plans to send around the world in 2022 and has delayed first-quarter shipments in Europe and lower-income countries such as the Philippines, public officials involved in their government's vaccine roll-outs told Reuters.
When the tiny company missed 2021 targets, buyers turned to rivals including Pfizer Inc/BioNTech SE, Moderna Inc, and Chinese drugmakers. "It's concerning when they have been saying they have been ready to ship millions of doses but the numbers you're hearing are different," said Mr Mayank Mamtani, a healthcare analyst at B. Riley Securities.
Low- and middle-income countries will feel the pinch the most if Novavax is missing planned shipments, said Mr Stephen Morrison, the director of the global health policy at Washington DC research group Centre for Strategic and International Studies.Novavax began delivering Serum Institute-produced doses to Indonesia late last year.
The initial shipments from Serum Institute were delivered to its distribution facility in the Netherlands and are awaiting final regulatory clearance for release, she said.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: straits_times - 🏆 5. / 69 Read more »
Source: thenewpaper - 🏆 7. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »